IRIS

TERRANOVA, NADIA

TERRANOVA, NADIA  

DIPARTIMENTO DI INGEGNERIA INDUSTRIALE E DELL'INFORMAZIONE  

Mostra records
Risultati 1 - 20 di 26 (tempo di esecuzione: 0.041 secondi).
Titolo Data di pubblicazione Autore(i) File
A data mining approach to evaluate the performance of recruitment centres in antidepressant drug clinical trials 1-gen-2010 Terranova, Nadia; R., Gomeni; I., Poggesi; Magni, Paolo
A mathematical model for assessing the glucose time course in critically ill patients 1-gen-2012 Terranova, Nadia; Magni, Paolo; F., Bertuzzi; R., Paino; M., Bonomo; Bellazzi, Riccardo
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 1-gen-2012 Magni, Paolo; Terranova, Nadia; DEL BENE, Francesca; Germani, MASSIMILIANO ENRICO; DE NICOLAO, Giuseppe
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 1-gen-2011 DEL BENE, Francesca; Terranova, Nadia; F., Fiorentini; Germani, MASSIMILIANO ENRICO; Magni, Paolo
A non parametric population approach for selecting biomarkers of a drug action 1-gen-2011 Terranova, Nadia; DEL BENE, Francesca; F., Fiorentini; Magni, Paolo; Germani, MASSIMILIANO ENRICO
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 1-gen-2013 Germani, MASSIMILIANO ENRICO; M., Rocchetti; DEL BENE, Francesca; Terranova, Nadia; I., Poggesi; DE NICOLAO, Giuseppe; Magni, Paolo
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 1-gen-2013 Terranova, Nadia; Germani, MASSIMILIANO ENRICO; DEL BENE, Francesca; Magni, Paolo
A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib 1-gen-2022 Tosca, E. M.; Terranova, N.; Stuyckens, K.; Dosne, A. G.; Perera, T.; Vialard, J.; King, P.; Verhulst, T.; Perez-Ruixo, J. J.; Magni, P.; Poggesi, I.
A tumor growth inhibition model in drugs combination regimens 1-gen-2012 Terranova, Nadia; DEL BENE, Francesca; Germani, MASSIMILIANO ENRICO; Magni, Paolo
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 1-gen-2014 Terranova, Nadia; DEL BENE, Francesca; Germani, MASSIMILIANO ENRICO; M., Rocchetti; Magni, Paolo
Assessing the glucose time course in critically ill patients by a mathematical model 1-gen-2011 Terranova, Nadia; Magni, Paolo; F., Bertuzzi; M., Bonomo; Bellazzi, Riccardo
Combining Reinforcement Learning and PK-PD models to personalize multiple drug administration: an application to Axitinib-Anti-Hypertensive treatment in metastatic renal cancer patients 1-gen-2024 De Carlo, A.; Tosca, E. M.; Terranova, N.; Magni, P.
Evaluation of a PK/PD DEB-based model for tumor-in-host growth kinetics under anticancer treatment 1-gen-2016 Tosca, ELENA MARIA; Borella, Elisa; Terranova, Nadia; Rocchetti, M.; Magni, Paolo
Evaluation of a tumor growth inhibition (TGI) model integrating dynamic energy budget (DEB) theory 1-gen-2016 Tosca, ELENA MARIA; Borella, Elisa; Terranova, Nadia; Rocchetti, M.; Magni, Paolo
Landscape on technical and conceptual requirements in Drug/Disease Modelling & Simulation 1-gen-2012 G., Vlasakakis; E., Comets; A., Drescher; I., Gueorguieva; Magni, Paolo; Terranova, Nadia; O., Della Pasqua; E. C., de Lange; C., Kloft
Mathematical modeling of growth and death dynamics of mouse embryonic stem cells irradiated with gamma-rays 1-gen-2014 Terranova, Nadia; Rebuzzini, Paola; Mazzini, G.; Borella, Elisa; Redi, CARLO ALBERTO; Zuccotti, M.; Garagna, Silvia; Magni, Paolo
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 1-gen-2013 Terranova, Nadia; Germani, MASSIMILIANO ENRICO; DEL BENE, Francesca; Magni, Paolo
Model Description Language (MDL) - a standard for model communication and interoperability 1-gen-2016 Smith, Mk; Moodie, S; Bizzotto, R; Blaudez, E; Borella, Elisa; Carrara, Letizia; Chan, P; Chenel, M; Comets, E; Gieschke, R; Harling, K; Harnisch, L; Hartung, N; Hooker, A; Karlsson, Mo; Kaye, R; Kloft, C; Kokash, N; Lavielle, M; Magni, Paolo; Mari, A; Mentre, F; Muselle, C; Nordgren, R; Nyberg, H; Parra Guillen, Zp; Pasotti, Lorenzo; Rode Kristensen, N; Smith, G; Swat, Mj; Terranova, Nadia; Yvon, F; Holford, NICHOLAS HUGH GEORGE
Model description language (MDL): a standard for pharmacometric modelling and simulation 1-gen-2017 Smith, Mk; Moodie, Sl; Bizzotto, R; Blaudez, E; Borella, E; Carrara, L; Chan, P; Chenel, M; Comets, E; Gieschke, R; Harling, K; Harnisch, L; Hartung, N; Hooker, A; Karlsson, Mo; Kaye, R; Kloft, C.; Kokash, N; Lavielle, M.; Magni, P; Mari, A; Mentré, F; Muselle, C; Nordgren, R; Nyberg, H; Parra-Guillén, Zp; Pasotti, L; Rode-Kristensen, N; Sardu, Ml; Smith, Gr; Swat, Mj; Terranova, N; Yngman, G; Yvon, F; Holford and on behalf of the DDMoRe consortium, N
Modeling tumor growth inhibition and toxicity outcome after administration of anticancer agents in xenograft mice: A Dynamic Energy Budget (DEB) approach 1-gen-2018 Terranova, N.; Tosca, E. M.; Borella, E.; Pesenti, E.; Rocchetti, M.; Magni, P.